Brandywine Global Investment Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Brandywine Global Investment Management’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-40,663	Closed	-$796K	–	720
2021 Q2	$796K	Sell	40,663 -2,600	-6%	-$54K	0.01%	580
2021 Q1	$920K	Sell	43,263 -304	-0.7%	-$8.82K	0.01%	560
2020 Q4	$1.29M	Sell	43,567 -2,610	-6%	-$66.3K	0.01%	514
2020 Q3	$1M	Buy	46,177 +4,946	+12%	+$113K	0.01%	500
2020 Q2	$920K	Buy	41,231 +363	+0.9%	+$7.08K	0.01%	513
2020 Q1	$623K	Buy	+40,868	New	+$732K	0.01%	545

Other funds holding RYTM

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brandywine Global Investment Management's RYTM Position: Q3 2021 in Review

Brandywine Global Investment Management sold out of Rhythm Pharmaceuticals (RYTM) in Q3 2021, closing a stake of 40,663 shares — an estimated $796K sold.

Brandywine Global Investment Management first reported a position in RYTM in Q1 2020 and held it in 6 quarters. The position peaked at $1.29M in Q4 2020. 97 funds tracked by Wall St. Rank hold RYTM as of Q3 2021.

Brandywine Global Investment Management reported no remaining Rhythm Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Brandywine Global Investment Management sold 40,663 Rhythm Pharmaceuticals shares in Q3 2021, an estimated $796K.
Brandywine Global Investment Management first reported a position in Rhythm Pharmaceuticals in Q1 2020 and held it in 6 quarters.
Brandywine Global Investment Management's Rhythm Pharmaceuticals position peaked at $1.29M in Q4 2020.
97 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2021.

Based on Brandywine Global Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.